199 related articles for article (PubMed ID: 9339151)
1. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative.
Am J Kidney Dis; 1997 Oct; 30(4 Suppl 3):S192-240. PubMed ID: 9339151
[No Abstract] [Full Text] [Related]
2. Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.
Collins AJ; Brenner RM; Ofman JJ; Chi EM; Stuccio-White N; Krishnan M; Solid C; Ofsthun NJ; Lazarus JM
Am J Kidney Dis; 2005 Sep; 46(3):481-8. PubMed ID: 16129210
[TBL] [Abstract][Full Text] [Related]
3. Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.
Aiello J
Nephrol Nurs J; 2002 Jun; 29(3):297-300. PubMed ID: 12164081
[TBL] [Abstract][Full Text] [Related]
4. Improving management of anemia using CQI techniques.
Berns JS; Cahill C; Okupinski V; O'Neill K
Nephrol News Issues; 1997 Sep; 11(9):11-3. PubMed ID: 9348865
[TBL] [Abstract][Full Text] [Related]
5. Reasons for producing guidelines on anemia of chronic renal failure: dialysis outcome quality initiative of the National Kidney Foundation.
Triolo G; Canavese C; Di Giulio S
Int J Artif Organs; 1998 Nov; 21(11):751-6. PubMed ID: 9894755
[TBL] [Abstract][Full Text] [Related]
6. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.
Am J Kidney Dis; 2001 Jan; 37(1 Suppl 1):S182-238. PubMed ID: 11229970
[No Abstract] [Full Text] [Related]
7. [Treatment experience with anemia in chronic kidney failure patients].
Shostka GD
Klin Med (Mosk); 1984 Jun; 62(6):60-6. PubMed ID: 6471800
[No Abstract] [Full Text] [Related]
8. The KDOQI clinical practice guidelines and clinical practice recommendations for treating anemia in patients with chronic kidney disease: implications for nurses.
McCarley P
Nephrol Nurs J; 2006; 33(4):423-6, 445; quiz 427-8. PubMed ID: 17002000
[TBL] [Abstract][Full Text] [Related]
9. NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative.
Am J Kidney Dis; 1997 Oct; 30(4 Suppl 3):S150-91. PubMed ID: 9339150
[No Abstract] [Full Text] [Related]
10. Timely correction of anemia at the initiation of dialysis. Case study of the anemic patient.
Breiterman-White R
Nephrol Nurs J; 2002 Oct; 29(5):469-72. PubMed ID: 12434453
[TBL] [Abstract][Full Text] [Related]
11. Managing the anemia of end-stage renal disease after hospitalization.
Krishnan M; Adams E
Nephrol Nurs J; 2004; 31(5):541-4. PubMed ID: 15518256
[TBL] [Abstract][Full Text] [Related]
12. Relative mortality and epoetin alpha dose among hemodialysis patients.
Coyne DW
Am J Kidney Dis; 2008 May; 51(5):866-7; author reply 867. PubMed ID: 18436101
[No Abstract] [Full Text] [Related]
13. Relative mortality and epoetin alpha dose in hemodialysis patients.
Cotter DJ; Thamer M; Zhang Y
Am J Kidney Dis; 2008 May; 51(5):865; author reply 865-6. PubMed ID: 18436099
[No Abstract] [Full Text] [Related]
14. [Contributions of the software La Clé Concerto in the implementation of the NKF-K/DOQI (National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative) recommendations for the control of mineral and bone metabolism disorders in the patient with chronic renal failure].
Ureña P
Nephrol Ther; 2008 Sep; 4 Spec No 1():9-14, 20-35. PubMed ID: 19031633
[No Abstract] [Full Text] [Related]
15. Anemia management protocols: providing consistent hemoglobin outcomes.
Michael M
Nephrol Nurs J; 2005; 32(4):423-6. PubMed ID: 16180783
[TBL] [Abstract][Full Text] [Related]
16. A lesson from the EPO mess: stop the cost shifting.
Amerling R
Nephrol News Issues; 2007 Jul; 21(8):52, 54-5, 68. PubMed ID: 17688232
[No Abstract] [Full Text] [Related]
17. Epoetin alfa: into the new millennium.
Adamson JW
Semin Oncol; 1998 Jun; 25(3 Suppl 7):76-9. PubMed ID: 9671336
[TBL] [Abstract][Full Text] [Related]
18. Anemia management practices in peritoneal dialysis patients. Case study of the anemic patient.
MacCracken MA
Nephrol Nurs J; 2001 Aug; 28(4):435-8. PubMed ID: 12143466
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of treatment with epoietin-alpha for patients with anaemia due to renal failure: the case of Sweden.
Glenngård AH; Persson U; Schön S
Scand J Urol Nephrol; 2008; 42(1):66-73. PubMed ID: 17907051
[TBL] [Abstract][Full Text] [Related]
20. Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI.
Eschbach JW
Semin Nephrol; 2000 Jul; 20(4):320-9. PubMed ID: 10928333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
